Exelixis Stock Options

EXEL Stock  USD 36.36  0.66  1.78%   
Exelixis' latest option contracts expiring on May 16th 2025 are carrying combined implied volatility of 0.6 with a put-to-call open interest ratio of 0.32 over 54 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on May 16th 2025. The total put volume is at 19.0, with calls trading at the volume of 335. This yields a 0.06 put-to-call volume ratio.

Open Interest Against May 16th 2025 Option Contracts

The chart above shows Exelixis' distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. Exelixis' open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for Exelixis' option, there is no secondary market available for investors to trade.

Exelixis Maximum Pain Price Across 2025-05-16 Option Contracts

Exelixis' max pain occurs when market makers reach a net positive position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthless.

In The Money vs. Out of Money Option Contracts on Exelixis

Analyzing Exelixis' in-the-money options over time can help investors to take a profitable long position in Exelixis regardless of its overall volatility. This is especially true when Exelixis' options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money Exelixis' options could be used as guardians of the underlying stock as they move almost dollar for dollar with Exelixis' stock while costing only a fraction of its price.

Exelixis In The Money Call Balance

When Exelixis' strike price is surpassing the current stock price, the option contract against Exelixis stock is said to be in the money. When it comes to buying Exelixis' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Exelixis are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.

Exelixis Current Options Market Mood

Exelixis' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Exelixis Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.

Put-to-Call Open Interest

Put-to-Call Volume

Unfortunately, most Exelixis' options investors are not very successful. Exelixis' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.

Rule 16 of the current Exelixis contract

Base on the Rule 16, the options market is currently suggesting that Exelixis will have an average daily up or down price movement of about 0.0375% per day over the life of the 2025-05-16 option contract. With Exelixis trading at USD 36.36, that is roughly USD 0.0136. If you think that the market is fully incorporating Exelixis' daily price movement you should consider buying Exelixis options at the current volatility level of 0.6%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
  
Purchasing Exelixis options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" Exelixis calls. Remember, the seller must deliver Exelixis stock to the call owner when a call is exercised.

Exelixis Option Chain

When Exelixis' strike price is surpassing the current stock price, the option contract against Exelixis stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Exelixis' option chain is a display of a range of information that helps investors for ways to trade options on Exelixis. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Exelixis. It also shows strike prices and maturity days for a Exelixis against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone.
Open IntStrike PriceCurrent SpreadLast Price
Call
EXEL250516C00055000155.00.0 - 0.70.27Out
Call
EXEL250516C00050000950.00.0 - 0.40.4Out
Call
EXEL250516C0004500050145.00.5 - 0.750.7Out
Call
EXEL250516C000440001844.00.65 - 0.91.55Out
Call
EXEL250516C000430004743.00.85 - 1.050.88Out
Call
EXEL250516C0004200010742.01.0 - 1.22.39Out
Call
EXEL250516C000410004041.01.2 - 1.42.7Out
Call
EXEL250516C000400009340.01.5 - 1.71.6Out
Call
EXEL250516C0003900059839.01.85 - 2.052.4Out
Call
EXEL250516C0003800020838.02.2 - 2.42.15Out
Call
EXEL250516C0003700039637.02.65 - 2.952.45Out
Call
EXEL250516C0003600022036.03.2 - 3.43.2In
Call
EXEL250516C00035000403735.03.8 - 4.03.71In
Call
EXEL250516C0003400017834.04.5 - 4.74.72In
Call
EXEL250516C0003300060133.05.2 - 5.55.6In
Call
EXEL250516C0003200026932.05.9 - 6.25.93In
Call
EXEL250516C0003100045531.06.7 - 7.07.1In
Call
EXEL250516C0003000091130.07.6 - 7.97.7In
Call
EXEL250516C000290001929.07.0 - 10.67.67In
Call
EXEL250516C0002800030328.09.1 - 10.19.7In
Call
EXEL250516C000270005227.09.5 - 11.110.73In
Call
EXEL250516C000260001426.010.1 - 13.411.4In
Call
EXEL250516C000250001025.010.7 - 14.410.8In
Call
EXEL250516C00024000124.011.4 - 14.610.58In
Call
EXEL250516C000230004223.013.2 - 15.514.5In
Call
EXEL250516C00022000122.013.3 - 17.36.0In
Call
EXEL250516C00020000420.015.6 - 19.313.95In
 Put
EXEL250516P00055000055.016.0 - 19.916.0In
 Put
EXEL250516P00050000050.011.2 - 15.011.2In
 Put
EXEL250516P00045000045.06.6 - 10.26.6In
 Put
EXEL250516P00044000044.05.7 - 9.15.7In
 Put
EXEL250516P00043000043.04.9 - 8.84.9In
 Put
EXEL250516P000420003942.05.7 - 6.25.7In
 Put
EXEL250516P00041000041.04.5 - 5.24.5In
 Put
EXEL250516P000400004440.04.2 - 4.44.2In
 Put
EXEL250516P0003900017239.03.5 - 3.83.7In
 Put
EXEL250516P000380004938.02.95 - 3.23.15In
 Put
EXEL250516P000370005837.02.35 - 2.82.75Out
 Put
EXEL250516P000360001136.01.9 - 2.152.02Out
 Put
EXEL250516P0003500048235.01.45 - 1.91.61Out
 Put
EXEL250516P000340007234.01.15 - 1.61.47Out
 Put
EXEL250516P0003300022133.00.85 - 1.41.05Out
 Put
EXEL250516P0003200035332.00.65 - 1.10.82Out
 Put
EXEL250516P0003100035331.00.55 - 0.750.65Out
 Put
EXEL250516P0003000067230.00.4 - 0.550.55Out
 Put
EXEL250516P000290001129.00.0 - 1.10.43Out
 Put
EXEL250516P0002800034428.00.0 - 0.40.3Out
 Put
EXEL250516P000270002227.00.0 - 0.60.45Out
 Put
EXEL250516P00026000126.00.0 - 1.550.2Out
 Put
EXEL250516P00025000125.00.0 - 2.21.05Out
 Put
EXEL250516P00024000224.00.0 - 1.450.93Out
 Put
EXEL250516P000230001723.00.0 - 2.150.45Out
 Put
EXEL250516P00021000121.00.0 - 1.40.27Out
 Put
EXEL250516P00020000120.00.0 - 1.40.75Out

Exelixis Selling And Marketing Expenses Over Time

   Selling And Marketing Expenses   
       Timeline  

Exelixis Total Stockholder Equity

Total Stockholder Equity

2.36 Billion

At this time, Exelixis' Total Stockholder Equity is quite stable compared to the past year.

Exelixis Corporate Management

Amy MDProduct VPProfile
Laura DillardExecutive ResourcesProfile
Tony RedmondSenior ResourcesProfile
Gregg BernierVP MarketingProfile
William MDSenior AffairsProfile
When determining whether Exelixis is a strong investment it is important to analyze Exelixis' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Exelixis' future performance. For an informed investment choice regarding Exelixis Stock, refer to the following important reports:
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Exelixis. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in income.
For more information on how to buy Exelixis Stock please use our How to buy in Exelixis Stock guide.
You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Exelixis. If investors know Exelixis will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Exelixis listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.754
Earnings Share
1.76
Revenue Per Share
7.478
Quarterly Revenue Growth
0.182
Return On Assets
0.1464
The market value of Exelixis is measured differently than its book value, which is the value of Exelixis that is recorded on the company's balance sheet. Investors also form their own opinion of Exelixis' value that differs from its market value or its book value, called intrinsic value, which is Exelixis' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Exelixis' market value can be influenced by many factors that don't directly affect Exelixis' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Exelixis' value and its price as these two are different measures arrived at by different means. Investors typically determine if Exelixis is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Exelixis' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.